Jpmorgan Chase & CO Hexo Corp. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.17 - $0.26 $1,110 - $1,698	6,534 Added 60.59%	17,318 $3,000
Q2 2022 Aug 11, 2022	SELL	$0.2 - $0.61 $2,909 - $8,872	-14,545 Reduced 57.42%	10,784 $2,000
Q1 2022 May 11, 2022	SELL	$0.48 - $0.74 $159,556 - $245,982	-332,409 Reduced 92.92%	25,329 $16,000
Q4 2021 Feb 10, 2022	BUY	$0.7 - $1.94 $25,496 - $70,660	36,423 Added 11.34%	357,738 $250,000
Q3 2021 Nov 12, 2021	BUY	$1.82 - $5.71 $584,793 - $1.83 Million	321,315 New	321,315 $591,000

23.7K

Ticker HEXO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 601,395,008
Description
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.